Skip to main content
ATRA filings

Corporate insider profile

Brian N Cherry Filing Activity

Latest reported as Director of Atara Biotherapeutics, Inc. (ATRA).

Purchase filings
1
Reported companies
1
Net open-market value
$999,994
Latest transaction
Sep 4, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 4, 2026Atara Biotherapeutics, Inc. (ATRA)DirectorOpen Market Purchase104,166$9.60$999,994